. . "Aspergillus pulmonary infections in patients without neutropenia - a literature review and our experience"@en . . "247856" . "1213-810X" . "Aspergilov\u00E9 plicn\u00ED infekce u nemocn\u00FDch bez neutropenie - p\u0159ehled literatury a na\u0161e zku\u0161enosti"@cs . "CZ - \u010Cesk\u00E1 republika" . . "5" . "Aspergillus pulmonary infections in patients without neutropenia - a literature review and our experience"@en . "4"^^ . . "3"^^ . . "Aspergilov\u00E9 plicn\u00ED infekce u nemocn\u00FDch bez neutropenie - p\u0159ehled literatury a na\u0161e zku\u0161enosti"@cs . "70" . "Aspergilov\u00E9 plicn\u00ED infekce u nemocn\u00FDch bez neutropenie - p\u0159ehled literatury a na\u0161e zku\u0161enosti" . "Studia pneumologica et phthiseologica" . "Homolka, J." . "Aspergilov\u00E9 plicn\u00ED infekce u nemocn\u00FDch bez neutropenie - p\u0159ehled literatury a na\u0161e zku\u0161enosti" . "RIV/00064190:_____/10:#0000062!RIV11-MZ0-00064190" . . . "N" . . . . "Acute and chronic pulmonary aspergillosis disease are severely immunocompromised patients, with chronic obstructive pulmonary disease or other preexisting lung disease. The work summarizes a set of 11 patients with pulmonary infections aspergillosis treated in 2007-2010 in FTNsP and LF UK mainly with chronic pulmonary aspergillosis. For diagnosis, we rely on radiological images, examination aspergillosis antigen (galaktomanan) in serum and bronchoalveolar lavage fluid (BALT), detection of antibodies in the serum, mycological examination of BALT and lung tissue obtained by transbronchial biopsy. In terms of classification requires knowledge of personal and pharmacological history and status of the immune system. In the treatment of patients with invasive aspergillosis and chronic pulmonary prefer voriconazole, patients with chronic forms is perhaps treatment with itraconazole in the form of orally administered suspension. Through a comprehensive approach there is a relapse of infection."@en . "\u0160terclov\u00E1, Martina" . "Va\u0161\u00E1kov\u00E1, Martina" . . "Akutn\u00ED i chronick\u00E1 plicn\u00ED aspergil\u00F3za jsou onemocn\u011Bn\u00ED t\u011B\u017Ece imunokompromitovan\u00FDch pacient\u016F, u nemocn\u00FDch s chronickou obstruk\u010Dn\u00ED plicn\u00ED nemoc\u00ED nebo jin\u00FDm preexistuj\u00EDc\u00EDm plicn\u00EDm onemocn\u011Bn\u00EDm. Pr\u00E1ce shrnuje soubor 11 nemocn\u00FDch s aspergilov\u00FDmi plicn\u00EDmi infekcemi l\u00E9\u010Den\u00FDch v 2007-2010 ve FTNsP a 1. LF UK p\u0159ev\u00E1\u017En\u011B s chronickou plicn\u00ED aspergil\u00F3zou. P\u0159i stanoven\u00ED diagn\u00F3zy se op\u00EDr\u00E1me o radiologick\u00FD obraz, vy\u0161et\u0159en\u00ED aspergilov\u00E9ho antigenu (galaktomananu) v s\u00E9ru a v bronchoalveol\u00E1rn\u00ED lav\u00E1\u017En\u00ED tekutin\u011B (BALT), pr\u016Fkazu protil\u00E1tek v s\u00E9ru, mykologick\u00E9 vy\u0161et\u0159en\u00ED BALT a tk\u00E1n\u011B z\u00EDskan\u00E9 transbronchi\u00E1ln\u00ED plicn\u00ED biopsi\u00ED. Z hlediska za\u0159azen\u00ED je nutn\u00E1 znalost osobn\u00ED a farmakologick\u00E9 anamn\u00E9zy a stavu imunitn\u00EDho syst\u00E9mu (vy\u0161et\u0159en\u00ED humor\u00E1ln\u00ED a bun\u011B\u010Dn\u00E9 imunity). V l\u00E9\u010Db\u011B nemocn\u00FDch s invazivn\u00ED i chronickou plicn\u00ED aspergil\u00F3zou preferujeme vorikonazol, u nemocn\u00FDch s chronick\u00FDmi formami je mo\u017En\u00E1 i l\u00E9\u010Dba itrakonazolem ve form\u011B peror\u00E1ln\u011B pod\u00E1van\u00E9 suspenze. P\u0159es komplexn\u00ED p\u0159\u00EDstup z\u016Fst\u00E1v\u00E1 progn\u00F3za v\u00E1\u017En\u00E1, doch\u00E1z\u00ED k recidiv\u00E1m infekce." . . "Chronic pulmonary aspergillosis; aspergilloma; aspergillosis; varikonazol"@en . "[F545095EA404]" . "Hric\u00EDkov\u00E1, Ivana" . "6"^^ . "Akutn\u00ED i chronick\u00E1 plicn\u00ED aspergil\u00F3za jsou onemocn\u011Bn\u00ED t\u011B\u017Ece imunokompromitovan\u00FDch pacient\u016F, u nemocn\u00FDch s chronickou obstruk\u010Dn\u00ED plicn\u00ED nemoc\u00ED nebo jin\u00FDm preexistuj\u00EDc\u00EDm plicn\u00EDm onemocn\u011Bn\u00EDm. Pr\u00E1ce shrnuje soubor 11 nemocn\u00FDch s aspergilov\u00FDmi plicn\u00EDmi infekcemi l\u00E9\u010Den\u00FDch v 2007-2010 ve FTNsP a 1. LF UK p\u0159ev\u00E1\u017En\u011B s chronickou plicn\u00ED aspergil\u00F3zou. P\u0159i stanoven\u00ED diagn\u00F3zy se op\u00EDr\u00E1me o radiologick\u00FD obraz, vy\u0161et\u0159en\u00ED aspergilov\u00E9ho antigenu (galaktomananu) v s\u00E9ru a v bronchoalveol\u00E1rn\u00ED lav\u00E1\u017En\u00ED tekutin\u011B (BALT), pr\u016Fkazu protil\u00E1tek v s\u00E9ru, mykologick\u00E9 vy\u0161et\u0159en\u00ED BALT a tk\u00E1n\u011B z\u00EDskan\u00E9 transbronchi\u00E1ln\u00ED plicn\u00ED biopsi\u00ED. Z hlediska za\u0159azen\u00ED je nutn\u00E1 znalost osobn\u00ED a farmakologick\u00E9 anamn\u00E9zy a stavu imunitn\u00EDho syst\u00E9mu (vy\u0161et\u0159en\u00ED humor\u00E1ln\u00ED a bun\u011B\u010Dn\u00E9 imunity). V l\u00E9\u010Db\u011B nemocn\u00FDch s invazivn\u00ED i chronickou plicn\u00ED aspergil\u00F3zou preferujeme vorikonazol, u nemocn\u00FDch s chronick\u00FDmi formami je mo\u017En\u00E1 i l\u00E9\u010Dba itrakonazolem ve form\u011B peror\u00E1ln\u011B pod\u00E1van\u00E9 suspenze. P\u0159es komplexn\u00ED p\u0159\u00EDstup z\u016Fst\u00E1v\u00E1 progn\u00F3za v\u00E1\u017En\u00E1, doch\u00E1z\u00ED k recidiv\u00E1m infekce."@cs . . . "RIV/00064190:_____/10:#0000062" . . .